Chinese biotech stocks hit by a double whammy, which means it’s time to buy
November 30, 2018 at 08:53 AM EST
The decline in biotech stocks is more about investors fleeing a high-beta group in a risk-off environment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.